Analyst stock forecast
Theravance Biopharma, Inc. - Ordinary Shares Stock Forecast and Analyst Price Target
TBPH analyst target range, upside, consensus rating and coverage count.
Direct answer
Theravance Biopharma, Inc. - Ordinary Shares's average price target is $17.67.
The target implies +4.4% from the recorded current price, and the consensus rating is none.
The verified range is $17.00 to $19.00, with 3 analysts in the current consensus when available.
Forecast evidence checked August 13, 2026.
Get free Theravance Biopharma, Inc. - Ordinary Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $16.92
- Average price target
- $17.67
- High price target
- $19.00
- Low price target
- $17.00
- Target upside
- +4.4%
- Consensus rating
- none
- Analysts
- 3
- Evidence date
- August 13, 2026
- Valid through
- August 20, 2026